Janus Henderson Group’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-24,887
| Closed | -$107K | – | 2613 |
|
|
2023
Q3 | $107K | Buy |
24,887
+5
| +0% | +$22 | ﹤0.01% | 2508 |
|
|
2023
Q2 | $164K | Sell |
24,882
-26
| -0.1% | -$171 | ﹤0.01% | 2497 |
|
|
2023
Q1 | $169K | Buy |
24,908
+13,762
| +123% | +$93.4K | ﹤0.01% | 2535 |
|
|
2022
Q4 | $82.3K | Sell |
11,146
-11,146
| -50% | -$82.3K | ﹤0.01% | 2363 |
|
|
2022
Q3 | $220K | Buy |
22,292
+11,162
| +100% | +$110K | ﹤0.01% | 2362 |
|
|
2022
Q2 | $122K | Sell |
11,130
-30,943
| -74% | -$339K | ﹤0.01% | 2439 |
|
|
2022
Q1 | $476K | Buy |
42,073
+30,937
| +278% | +$350K | ﹤0.01% | 1953 |
|
|
2021
Q4 | $175K | Buy |
+11,136
| New | +$175K | ﹤0.01% | 2429 |
|
|
2021
Q1 | – | Sell |
-77,171
| Closed | -$1.01M | – | 1634 |
|
|
2020
Q4 | $1.01M | Buy |
77,171
+7,511
| +11% | +$98.7K | ﹤0.01% | 1201 |
|
|
2020
Q3 | $673K | Buy |
69,660
+6,554
| +10% | +$63.3K | ﹤0.01% | 1186 |
|
|
2020
Q2 | $722K | Buy |
63,106
+30,237
| +92% | +$346K | ﹤0.01% | 1153 |
|
|
2020
Q1 | $341K | Buy |
+32,869
| New | +$341K | ﹤0.01% | 1216 |
|